Risk factors for subretinal fibrosis after anti-VEGF treatment of myopic choroidal neovascularisation.

Hu XiaoXiujuan ZhaoSongshan LiLimei SunWen XinZhirong WangAiyuan ZhangJunyan ZhangXiaoyan Ding

Published in: The British journal of ophthalmology (2020)

The incidence of subretinal fibrosis after anti-VEGF therapy was 40.7% in eyes with mCNV. Age, baseline BCVA and MI index could serve as predictive risk factors of subretinal fibrosis after anti-VEGF treatment in patients with mCNV.

Keyphrases

risk factors
vascular endothelial growth factor
endothelial cells
optical coherence tomography
stem cells
liver fibrosis
cell therapy